Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
114.6 USD | -1.25% |
|
+3.45% | -7.64% |
17/07 | Leerink Adjusts Price Target on DexCom to $151 From $161 | MT |
15/07 | Morgan Stanley Cuts Price Target on DexCom to $120 From $132, Keeps Equalweight Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.64% | 46.16B | |
-4.90% | 179B | |
-1.36% | 100B | |
+13.08% | 44.81B | |
+9.63% | 44.38B | |
+13.63% | 29.53B | |
+21.03% | 25.83B | |
-7.12% | 23.97B | |
+4.03% | 22.5B | |
-8.75% | 22.11B |
- Stock Market
- Equities
- DXCM Stock
- News DexCom, Inc.
- Transcript : DexCom, Inc. Presents at 31st Annual JPMorgan Healthcare Conference, Jan-07-2013 03